Community Health Systems (NYSE:CYH) Downgraded by Wall Street Zen to Sell

Wall Street Zen lowered shares of Community Health Systems (NYSE:CYH) from a hold rating to a sell rating in a research report sent to investors on Saturday.

Several other equities research analysts also recently issued reports on CYH. Barclays reduced their price objective on Community Health Systems from $3.50 to $3.00 and set an “equal weight” rating for the company in a research note on Thursday. Zacks Research raised Community Health Systems from a “hold” rating to a “strong-buy” rating in a research note on Monday, February 23rd. Truist Financial reduced their price objective on Community Health Systems from $3.50 to $3.00 and set a “hold” rating for the company in a research note on Thursday. UBS Group increased their price objective on Community Health Systems from $3.60 to $3.70 and gave the stock a “neutral” rating in a research note on Friday, February 20th. Finally, Wells Fargo & Company dropped their target price on Community Health Systems from $3.00 to $2.00 and set an “underweight” rating on the stock in a research report on Wednesday, January 7th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $3.28.

Community Health Systems Trading Up 9.4%

Shares of Community Health Systems stock opened at $2.73 on Friday. The stock has a 50-day moving average price of $3.17 and a 200 day moving average price of $3.27. The company has a market cap of $384.01 million, a P/E ratio of 0.79 and a beta of 1.97. Community Health Systems has a 1 year low of $2.38 and a 1 year high of $4.47.

Community Health Systems (NYSE:CYH) last announced its quarterly earnings data on Tuesday, April 21st. The company reported ($0.48) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by ($0.30). The business had revenue of $2.97 billion during the quarter, compared to analysts’ expectations of $2.89 billion. Community Health Systems had a negative return on equity of 7.62% and a net margin of 3.78%.The firm’s revenue was down 6.1% on a year-over-year basis. During the same period in the prior year, the company posted ($0.03) earnings per share. Community Health Systems has set its FY 2026 guidance at -0.600-0.000 EPS. On average, equities analysts forecast that Community Health Systems will post -0.42 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of CYH. Royal Bank of Canada increased its position in Community Health Systems by 601.9% in the 4th quarter. Royal Bank of Canada now owns 9,286 shares of the company’s stock worth $29,000 after purchasing an additional 7,963 shares during the last quarter. Wealth Enhancement Advisory Services LLC acquired a new position in Community Health Systems in the 3rd quarter worth about $32,000. Lazard Asset Management LLC acquired a new position in Community Health Systems in the 4th quarter worth about $34,000. Wealthcare Advisory Partners LLC acquired a new position in shares of Community Health Systems during the 4th quarter valued at about $35,000. Finally, Valeo Financial Advisors LLC acquired a new position in shares of Community Health Systems during the 4th quarter valued at about $39,000. 84.99% of the stock is owned by institutional investors and hedge funds.

Community Health Systems Company Profile

Community Health Systems, Inc (NYSE: CYH) is one of the largest publicly traded hospital operators in the United States. Headquartered in Franklin, Tennessee, the company owns, leases and manages general acute care hospitals and outpatient facilities, primarily in non-urban and mid-market communities. CHS is focused on delivering locally accessible healthcare services through its network of affiliated hospitals, clinics and post-acute providers.

The company’s core offerings include inpatient medical and surgical care, emergency services, critical care, diagnostic imaging and laboratory testing.